RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Hiroshi Matsui to Cyclin-Dependent Kinase Inhibitor p21

Back to Details
This is a "connection" page, showing publications Hiroshi Matsui has written about Cyclin-Dependent Kinase Inhibitor p21.
Hiroshi Matsui
Connection Strength
0.059
Cyclin-Dependent Kinase Inhibitor p21
  1. Chen Q, Dorji JP, Perera SG, Li P, Aijaz F, Ihuoma LC, Matsui H, Awah CU. In vivo inhibition of c-MYC in the metastatic drug-resistant ovarian cancer cells down regulates the c-MYC-PD-L1-PAX8-p21 to achieve therapeutic efficacy. BMC Cancer. 2025 Dec 10; 26(1):68.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support